Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R7EA
|
||||
Former ID |
DIB018007
|
||||
Drug Name |
methyl 5-[(4-tert-butylbenzoyl)amino]-2H-1,2,4-triazole-3-carboxylate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Clinical trial | [541677] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H18N4O3
|
||||
InChI |
InChI=1S/C15H18N4O3/c1-15(2,3)10-7-5-9(6-8-10)12(20)17-14-16-11(18-19-14)13(21)22-4/h5-8H,1-4H3,(H2,16,17,18,19,20)
|
||||
InChIKey |
LVKKWCOINMSBPK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of Coagulation factor XII | Target Info | Inhibitor | [543605] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Blood coagulation | ||||
PathWhiz Pathway | Coagulation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.